Benjamin Esparaz is an expert in the field of Hematology. He over the years received 1 awards: "Fellow (FACP)". Benjamin T. Esparaz is also a published doctor. He has 10 paper published. The most recent paper is: Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study. He is registered with Medicare and accepts Medicare payments.
NPI NUMBER | 1275502940 | |
NPPES Provider LastName | ESPARAZ | |
NPPES Provider FirstName | BENJAMIN | |
NPPES Provider ZIPCode | 625265858 | |
NPPES Provider State | IL | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 1985.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 192.0 | |
Percent Opioid Claims | 9.67 |
National Provider Identifier [NPI] | 1275502940 |
Last Name Of The Provider | ESPARAZ |
First Name Of The Provider | BENJAMIN |
View All |
![]() |
Dr. Sebastien S. Kairouz, MD
![]() |
![]() |
Dr. Perry P. Guaglianone, MD
![]() |
![]() |
Dr. David M. Johnson, MD
![]() |
![]() |
Dr. Mario R. Velasco, MD
![]() |
![]() |
Dr. Dolores A. Estrada, MD
![]() |